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To assess the prevalence of malaria among illegal gold 
miners in the French Guiana rainforest, we screened 205 
miners during May–June 2014. Malaria prevalence was 
48.3%; 48.5% of cases were asymptomatic. Patients 
reported self-medication with artemisinin-based combina-
tion therapy. Risk for emergence and spread of artemisinin 
resistance among gold miners in the rainforest is high.
Malaria control programs on the Guiana Shield, a re-gion of South America, are challenged by migrant 
populations looking for gold. Since 2008, the “Harpie” 
operation to control and reduce illegal gold mining activi-
ties has been conducted by French Armed Forces in French 
Guiana. Military deployments at illegal gold mining sites 
have resulted in several outbreaks and increased incidence 
of malaria in French forces (1–4), which suggests high 
transmission levels in those areas. Illegal gold mining sites 
are isolated places in the rainforest, far from health posts. 
The miners are usually hidden in the forest to avoid police 
controls, and they live in unsanitary conditions.
Although formal health monitoring is not carried out 
in these communities, the effects of infectious diseases 
are of concern. In 2013, a group of 34 illegal gold min-
ers with severe diarrheic and respiratory symptoms were 
evacuated by plane from a health post to the reference 
regional hospital in Cayenne. The outbreak was attrib-
uted to co-infection with several parasitic, bacterial, or 
viral agents: seasonal influenza A(H1N1)pdm09, Shigella 
flexnieri, Necator americanus, Leishmania spp., Strep-
tococcus pneumoniae, and Plasmodium vivax (5). All 
patients came from the illegal gold mining site of Eau 
Claire (3°36′00′′N, 53°34′60′′W) (Figure 1). Given these 
problems, French health authorities decided to provide 
primary medical care in the field and also to assess the 
sanitary situation in Eau Claire. We describe the results 
of the cross-sectional study conducted to assess the epide-
miologic situation of malaria.
The Study
Because of violence and insecure conditions at illegal min-
ing sites, French military health services conducted the 
mission. Twelve soldiers and military policemen accom-
panied the medical team to ensure their protection but also 
that of the miners’ community. A primary care clinic and 
laboratory were set up under tents at the Eau Claire gold 
mining camp from May 28, 2014, through June 6, 2014. 
Active malaria screening was offered to every person who 
sought care for any reason. 
Diagnostic tests associating the malaria rapid diag-
nosis test (RDT) (SD Bioline Malaria Ag Pf/Pan; Stan-
dard Diagnostics, Inc., Giheung-gu, South Korea) and 
thin blood films were performed in the field. Patients who 
had positive results of an RDT, thin blood film, or both 
received treatment. 
Data were collected by physicians concerning each 
person’s recent medical history, protection measures 
against mosquito bites, use of medications, and recent 
travel inside or outside of French Guiana. Patient anonym-
ity was stringently respected; every patient was issued a 
unique identification number. Only verbal consent could be 
obtained to avoid references that might reveal the identity 
of undocumented persons engaged in illegal activities. 
Dried blood spots were obtained on filter paper by 
fingerstick and packaged in individual plastic bags with 
a desiccant until processing. Plasmodium DNA was ex-
tracted subsequently and tested with a nested PCR tar-
geting P. falciparum and P. vivax 18S rRNA genes, 
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DISPATCHES
according to the method of Snounou et al. (6). The propel-
ler domain of pfK13 gene was sequenced in P. falciparum 
isolates (7).
We defined Plasmodium infection as a positive RDT, 
thin blood film, or PCR result. Symptomatic Plasmodium 
infection was defined as a positive test result and fever (his-
tory of fever in preceding 24 hours and/or documented tem-
perature >38°C during medical examination) and/or >2 of 
the following: nausea, vomiting, diarrhea, abdominal pain, 
anorexia, headache, or jaundice. Other Plasmodium infec-
tions were classified as asymptomatic.
Overall, 205 persons freely sought medical care 
and accepted malaria screening. The sex ratio was 2.0 
(137 [66.8%] men; 68 [33.2%] women). Median age 
was 39 years (interquartile range [IQR] 32–46 years; 
range 20–63 years). The workers had been gold panning 
for a median time of 7 years (IQR 3–14 years; range 
1 month–44 years) and on illegal gold mining sites in 
French Guiana for a median time of 4 years (IQR 1–8 
years; range 1 month–25 years). Most (97.6%, 200) pa-
tients came from Brazil, 4 (2.0%) came from Suriname, 
and 1 (0.5%) came from Guyana. Before their arrival 
at Eau Claire, patients had lived in Brazil (41.0%, 84), 
Suriname (24.9%, 51), or at another illegal gold min-
ing site (19/69 [33.7%] different sites throughout inland 
French Guiana and 1 unknown site) (Figure 1). During 
the previous year, 66.0% (135/205) persons had trav-
eled to >1 area outside Eau Claire: 54.1% (111/205) to 
Suriname (among those, 60.0% had traveled there >2 
times); 22.4% (46/205) to Brazil; and 18.5% (38/205) to 
the main cities in the malaria-free area along the French 
Guiana coast (Figure 2).
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Figure 1. Origins of gold miners (N = 205) before they began to 
work in the illegal gold mining site of Eau Claire, French Guiana. 
Inset shows location of French Guiana in South America.
Figure 2. Travels of gold miners (N = 205) living in Eau Claire, 
French Guiana, 2013–2014. Inset shows location of French 
Guiana in South America.
 
 
 
Table 1. Malaria and fever episodes reported by illegal gold 
miners, French Guiana, 2013–2014* 
Episodes 
No. (%) patients, 
N = 205 
Malaria episode  
 No 84 (41.0) 
 Yes 121 (59.0) 
 No. episodes  
  1 27 (22.3) 
  2–4 48 (39.7) 
  >4 45 (37.2) 
  NA 1 (0.8) 
Fever episode   
 No 46 (22.4) 
 Yes 156 (76.1) 
 NA 3 (1.5) 
 No. episodes  
  1 23 (14.8) 
  2–4 74 (47.4) 
  >4 57 (36.5) 
  NA 2 (1.3) 
*NA, no answer. 
 
 
Artemisinin Resistance, French Guiana
Of the 205 patients, 156 (76.1%) reported >1 fever 
episode and 131 (63.9%) reported several (2–>4) episodes; 
121 (59.0%) reported >1 malaria episode and 93 (45.4%) 
several episodes (Table 1). Self-medication with antima-
larial drugs was reported by 120 (58.5%) patients, of whom 
118 (98.3%) had reported malaria episodes in the past year. 
Artemisinin-based combination therapies (ACTs) were 
mainly used: dihydroartemisinin/piperaquine/trimethoprim 
(Artecom; Chongqing Tonghe Pharmaceutical Co. Ming-
shan Town, China) by 79 (63.7%) and artemether-lume-
fantrine (Coartem; Novartis Pharmaceuticals Corp. Basel, 
Switzerland) by 32 (26.7%). Chloroquine was also used 
alone or with ACTs by 13 (10.8%) patients. The medi-
cation schedules used were not clearly identified, but 53 
(44.2%) patients took drugs for 1 or 2 days only. Nets were 
used by 37 (18.0%) and mosquito repellents by 41 (20.5%) 
of the 205 patients. 
The overall prevalence of malaria infection was 48.3% 
(99/205). P. falciparum and P. vivax single infections ac-
counted for 44.4% (44/99) and 29.3% (29/99) cases, re-
spectively, and mixed infection with P. falciparum and P. 
vivax for 26.3% (26/99) (Table 2). RDTs, thin blood films, 
and PCR were positive for 40.4% (40/99), 32.3% (32/99), 
and 97.0% (96/99) of patients classified as positive for 
malaria, respectively. Asymptomatic infections accounted 
for 48.5% (48/99) of cases. Low parasitemia levels were 
systematically observed. Only 1 person had a parsitemia 
level >1%, and no differences in level were found between 
symptomatic and asymptomatic infections. The propeller 
region of the pfK13 gene was successfully sequenced in 26 
P. falciparum isolates without any mutation detected.
Conclusions
During the 10 days of field work, almost all inhabitants of 
the gold mining site sought medical care. The high preva-
lence of malaria and asymptomatic Plasmodium infections 
observed confirms that malaria is hyperendemic there (8). 
Because of the mobility of gold miners within French Gui-
ana, malaria also could be highly prevalent among persons 
at other illegal gold mining sites where competent vectors 
exist (3). This hypothesis is strengthened by the recurrent 
malaria outbreaks experienced by French forces involved 
in operations to control illegal gold mining, particularly in 
the center of the region (3). 
Systematic self-medication by patients using ACTs 
without following a full course of treatment is a serious 
risk for emergence of resistance to artemisinin and associ-
ated drugs (9). The high price of ACTs in the field (2 g 
gold) was the primary reason patients gave for not complet-
ing treatments. The mobility of gold miners raises 2 issues: 
the reintroduction of the disease in malaria-free areas (10) 
and the spread of antimalarial drug resistance if the disease 
emerges (11). In 2013, parasite persistence on day 3 after 
treatment with Coartem was described in Suriname, and 
most participants in that study had worked in gold mines in 
French Guiana (12,13). In Guyana, pfK13 C580Y mutants 
obtained from samples in 2010 were recently reported (14). 
These results may be viewed as ominous. Collaboration 
between countries of the Guiana Shield to control malaria 
among mobile populations is urgently needed (15).
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